{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T09:30:25Z","timestamp":1648891825739},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s11908-009-0060-0","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T00:24:18Z","timestamp":1257380658000},"page":"417-419","source":"Crossref","is-referenced-by-count":1,"title":["Update on invasive opportunistic mycoses: Clinical trials review, 2008\u20132009"],"prefix":"10.1007","volume":"11","author":[{"given":"Andreas H.","family":"Groll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,6]]},"reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/598933","volume":"48","author":"R.F. Betts","year":"2009","unstructured":"Betts RF, Nucci M, Talwar D, et al.; Caspofungin High-Dose Study Group: A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. Clin Infect Dis 2009, 48:1676\u20131684.","journal-title":"Clin Infect Dis"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/AAC.45.10.2845-2855.2001","volume":"45","author":"A.H. Groll","year":"2001","unstructured":"Groll AH, Mickiene D, Petraitiene R, et al.: Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling. Antimicrob Agents Chemother 2001, 45:2845\u20132855.","journal-title":"Antimicrob Agents Chemother"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","volume":"39","author":"J. Maertens","year":"2004","unstructured":"Maertens J, Raad I, Petrikkos G, et al.; Caspofungin Salvage Aspergillosis Study Group: Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004, 39:1563\u20131571.","journal-title":"Clin Infect Dis"},{"key":"60_CR4","unstructured":"Herbrecht R, Maertens J, Baila L, et al.: Caspofungin as first-line therapy of invasive aspergillosis in allogeneic hematopoietic stem cell transplant recipients: a study of the EORTC Infectious Diseases Group [abstract M2167]. Presented at the American Society for Microbiology 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC; October 25\u201327, 2008."},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/CCM.0b013e31818b3477","volume":"36","author":"A.J. Labelle","year":"2008","unstructured":"Labelle AJ, Micek ST, Roubinian N, Kollef MH: Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008, 36:2967\u20132972.","journal-title":"Crit Care Med"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","volume":"149","author":"M.G. Schuster","year":"2008","unstructured":"Schuster MG, Edwards JE Jr, Sobel JD, et al.: Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008, 149:83\u201390.","journal-title":"Ann Intern Med"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"O.A. Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, et al.: Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007, 356:348\u2013359.","journal-title":"N Engl J Med"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"A.J. Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, et al.: Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007, 356:335\u2013347.","journal-title":"N Engl J Med"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","volume":"46","author":"B.J. Rijnders","year":"2008","unstructured":"Rijnders BJ, Cornelissen JJ, Slobbe L, et al.: Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis 2008, 46:1401\u20131408.","journal-title":"Clin Infect Dis"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","volume":"46","author":"A. Pascual","year":"2008","unstructured":"Pascual A, Calandra T, Bolay S, et al.: Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008, 46:201\u2013211.","journal-title":"Clin Infect Dis"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-009-0060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-009-0060-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-009-0060-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:22:11Z","timestamp":1559420531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-009-0060-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11908-009-0060-0","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}